Literature DB >> 20613524

Accommodation in renal transplantation: unanswered questions.

Raymond J Lynch1, Jeffrey L Platt.   

Abstract

PURPOSE OF REVIEW: Accommodation, an acquired resistance of an organ to immune-mediated damage, has been recognized as an outcome of renal transplantation for more than 20 years. Accommodation was originally identified in blood group-incompatible kidney transplants that survived and functioned normally in recipients with high titers of antiblood group antibodies directed against antigens in the grafts. The most compelling questions today include how often and by which mechanisms accommodation occurs, and what might be the biological implications of accommodation. This communication summarizes recent advances in addressing these questions. RECENT
FINDINGS: Because its diagnosis has depended on identification of antidonor antibodies in serum, the prevalence of accommodation has been considered low. Recent research in animal models and clinical subjects may challenge that view. This research also suggests that sublethal graft injury of various types induces accommodation and that accommodation may be a dynamic condition, eventuating into tolerance on the one hand and chronic graft injury on the other.
SUMMARY: Burgeoning lines of investigation into accommodation now portray a condition of greater prevalence than once thought, exposing pathways that may contribute to the understanding of a range of responses to transplantation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20613524      PMCID: PMC3085890          DOI: 10.1097/MOT.0b013e32833b9c25

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  44 in total

1.  Antigen expression in xenotransplantation: how low must it go?

Authors:  W Parker; S S Lin; J L Platt
Journal:  Transplantation       Date:  2001-01-27       Impact factor: 4.939

2.  Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy.

Authors:  Christopher J Sonnenday; Daniel S Warren; Mathew Cooper; Milagros Samaniego; Mark Haas; Karen E King; R Sue Shirey; Christopher E Simpkins; Robert A Montgomery
Journal:  Am J Transplant       Date:  2004-08       Impact factor: 8.086

Review 3.  Accommodation: preventing injury in transplantation and disease.

Authors:  Cody A Koch; Zain I Khalpey; Jeffrey L Platt
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

4.  ABO-incompatible kidney transplantation: initial immunopathologic evaluation.

Authors:  M W Chopek; R L Simmons; J L Platt
Journal:  Transplant Proc       Date:  1987-12       Impact factor: 1.066

5.  Present experiences in a series of 26 ABO-incompatible living donor renal allografts.

Authors:  G P Alexandre; J P Squifflet; M De Bruyère; D Latinne; R Reding; P Gianello; M Carlier; Y Pirson
Journal:  Transplant Proc       Date:  1987-12       Impact factor: 1.066

6.  Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.

Authors:  B Sis; M Mengel; M Haas; R B Colvin; P F Halloran; L C Racusen; K Solez; W M Baldwin; E R Bracamonte; V Broecker; F Cosio; A J Demetris; C Drachenberg; G Einecke; J Gloor; D Glotz; E Kraus; C Legendre; H Liapis; R B Mannon; B J Nankivell; V Nickeleit; J C Papadimitriou; P Randhawa; H Regele; K Renaudin; E R Rodriguez; D Seron; S Seshan; M Suthanthiran; B A Wasowska; A Zachary; A Zeevi
Journal:  Am J Transplant       Date:  2010-01-29       Impact factor: 8.086

7.  Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg).

Authors:  Denis Glotz; Corinne Antoine; Pierre Julia; Caroline Suberbielle-Boissel; Samir Boudjeltia; Rabah Fraoui; Chafic Hacen; Alain Duboust; Jean Bariety
Journal:  Am J Transplant       Date:  2002-09       Impact factor: 8.086

Review 8.  Incompatible kidney transplantation: lessons from a decade of desensitization and paired kidney exchange.

Authors:  Daniel S Warren; Robert A Montgomery
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

9.  The role of antibodies and von Willebrand factor in discordant pulmonary xenotransplantation.

Authors:  Christine L Lau; Edward Cantu; Gonzalo V Gonzalez-Stawinski; Zoie E Holzknecht; Timothy C Nichols; Katherine E Posther; Cory A Rayborn; Jeffrey L Platt; William Parker; R Duane Davis
Journal:  Am J Transplant       Date:  2003-09       Impact factor: 8.086

10.  Characteristics of CD59 up-regulation induced in porcine endothelial cells by alphaGal ligation and its association with protection from complement.

Authors:  Brian C Grubbs; Barbara A Benson; Agustin P Dalmasso
Journal:  Xenotransplantation       Date:  2003-09       Impact factor: 3.907

View more
  8 in total

1.  Revisiting traditional risk factors for rejection and graft loss after kidney transplantation.

Authors:  T B Dunn; H Noreen; K Gillingham; D Maurer; O G Ozturk; T L Pruett; R A Bray; H M Gebel; A J Matas
Journal:  Am J Transplant       Date:  2011-08-03       Impact factor: 8.086

Review 2.  Tissue tolerance: a distinct concept to control acute GVHD severity.

Authors:  Shin-Rong Wu; Pavan Reddy
Journal:  Blood       Date:  2017-02-02       Impact factor: 22.113

3.  Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients.

Authors:  Adnan Sharif; Nada Alachkar; Serena Bagnasco; Duvuru Geetha; Gaurav Gupta; Karl Womer; Lois Arend; Lorraine Racusen; Robert Montgomery; Edward Kraus
Journal:  Clin J Am Soc Nephrol       Date:  2012-05-24       Impact factor: 8.237

4.  Reduced Expression of Membrane Complement Regulatory Protein CD59 on Leukocytes following Lung Transplantation.

Authors:  Laura A Michielsen; Kevin Budding; Daniël Drop; Ed A van de Graaf; Tineke Kardol-Hoefnagel; Marianne C Verhaar; Arjan D van Zuilen; Henny G Otten
Journal:  Front Immunol       Date:  2018-01-22       Impact factor: 7.561

5.  Effects of Neutralization by Soluble ABH Antigens Produced by Transplanted Kidneys From ABO-Incompatible Secretor Donors.

Authors:  Jieun Kim; Sinyoung Kim; In Sik Hwang; Jong Rak Choi; Jae Geun Lee; Yu Seun Kim; Myoung Soo Kim; Hyun Ok Kim
Journal:  Ann Lab Med       Date:  2017-05       Impact factor: 3.464

Review 6.  Cell Fusion in Malignancy: A Cause or Consequence? A Provocateur or Cure?

Authors:  Jeffrey L Platt; Marilia Cascalho
Journal:  Cells       Date:  2019-06-14       Impact factor: 6.600

7.  Treatment of large plasma volumes using specific immunoadsorption to desensitize ABO-incompatible kidney-transplant candidates.

Authors:  Lionel Rostaing; Asma Allal; Arnaud Del Bello; Federico Sallusto; Laure Esposito; Nicolas Doumerc; Bénédicte Debiol; Audrey Delas; Xavier Game; Nassim Kamar
Journal:  J Nephropathol       Date:  2016-06-29

8.  Association Between Promoter Polymorphisms in CD46 and CD59 in Kidney Donors and Transplant Outcome.

Authors:  Laura A Michielsen; Arjan D van Zuilen; Tineke Kardol-Hoefnagel; Marianne C Verhaar; Henny G Otten
Journal:  Front Immunol       Date:  2018-05-14       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.